material into the target cells 1 . For viral vector-based delivery, recombinant Adeno associated viruses (rAAVs) [...] Following the initial approvals of treatments based on rAAVs in the last ten years 2,3 , AAV production [...] methods necessitates a shift towards knowledge-based processes, enabling cost-effective and sufficient